Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
JAB-2485 is an inhibitor of Aurora A kinase (IC50 = 0.327 nM).1 It is selective for Aurora A over Aurora B and Aurora C kinases at 2 µM. JAB-2485 decreases levels of phosphorylated Aurora A kinase in NCI H446 small-cell lung cancer cells (IC50 = 2.08 nM) and reduces the viability of 11 lung cancer cell lines (IC50s = 29.7-982 nM). JAB-2485 (0.3, 1, and 3 µM) induces apoptosis and cell cycle arrest at the G2/M phase in NCI H446 cells. It decreases tumor volume without affecting body weight in an NCI H446 mouse xenograft model when administered at doses of 10 or 20 mg/kg per day.
WARNING This product is not for human or veterinary use.
1. Preclinical evaluation of JAB-